IRIS
FANIN, Renato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.571
EU - Europa 5.111
AS - Asia 1.166
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 4
OC - Oceania 2
Totale 26.897
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.450
UA - Ucraina 1.957
DE - Germania 805
CN - Cina 791
IT - Italia 645
FI - Finlandia 588
SE - Svezia 441
IE - Irlanda 348
TR - Turchia 160
CA - Canada 118
GB - Regno Unito 99
VN - Vietnam 85
FR - Francia 84
IN - India 49
RU - Federazione Russa 38
IR - Iran 37
BE - Belgio 21
EU - Europa 17
TG - Togo 17
CZ - Repubblica Ceca 14
KR - Corea 14
NL - Olanda 14
PL - Polonia 11
JP - Giappone 10
RO - Romania 10
ES - Italia 7
RS - Serbia 7
HK - Hong Kong 6
ID - Indonesia 6
ZA - Sudafrica 6
CH - Svizzera 5
BG - Bulgaria 4
BR - Brasile 4
AT - Austria 3
EG - Egitto 3
IL - Israele 3
AU - Australia 2
GR - Grecia 2
LU - Lussemburgo 2
MX - Messico 2
SG - Singapore 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
GL - Groenlandia 1
HU - Ungheria 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
PT - Portogallo 1
Totale 26.897
Salva come PNG Salva come JPEG
Città #
Fairfield 2.969
Woodbridge 2.722
Houston 1.870
Ann Arbor 1.792
Jacksonville 1.310
Ashburn 1.278
Seattle 1.211
Wilmington 1.102
Chandler 1.036
Cambridge 972
Dearborn 843
Beijing 395
Princeton 361
Dublin 348
Udine 272
San Diego 177
Izmir 160
Ogden 92
Ottawa 91
Dong Ket 84
Norwalk 80
Des Moines 72
Boardman 58
Hefei 57
Nanjing 53
Redmond 50
Trieste 45
New York 41
Kunming 38
Milan 33
Regensburg 29
Simi Valley 26
Nanchang 23
Brussels 21
Guangzhou 21
Hangzhou 21
Saint Petersburg 21
Jinan 20
Leawood 19
Grafing 18
Toronto 18
Lomé 17
Helsinki 16
Venezia 15
Fuzhou 14
Shenyang 14
Andover 13
Falls Church 13
Phoenix 13
Chengdu 12
Wuhan 12
Augusta 11
San Mateo 11
Washington 11
Monmouth Junction 10
Warsaw 10
Ardabil 9
Duino-Aurisina 9
Zanjan 9
Brno 8
Indiana 8
Zhengzhou 8
Belgrade 7
Redwood City 7
Tokyo 7
Chongqing 6
Hebei 6
Hong Kong 6
London 6
Modderfontein 6
Montreal 6
Amsterdam 5
Changsha 5
Edinburgh 5
Frankfurt am Main 5
Horia 5
Mumbai 5
Murano 5
Ningbo 5
Prague 5
Rome 5
Spinea 5
Chaoyang 4
Florence 4
Henderson 4
Madrid 4
Pune 4
Quzhou 4
Sacramento 4
Zurich 4
Bangalore 3
Dallas 3
Fiumicino 3
Jakarta 3
Lappeenranta 3
Padova 3
Pordenone 3
Rovigo 3
Sacile 3
Santa Clara 3
Totale 20.266
Salva come PNG Salva come JPEG
Nome #
Prognostic significance of the detection of tumour cells in peripheral blood stem cell collections in stage II and III breast cancer patients treated with high-dose therapy 232
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party 195
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 170
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies 152
Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review 144
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia. 142
The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery 140
Atypical haemolytic-uraemic syndrome at the onset of acute promyelocytic leukaemia. 139
Low-dose rituximab in adult patients with primary immune thrombocytopenia. 135
The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation 135
Abdominal abscess and Hafnia alvei septicemia occurring during the aplastic phase after autologous stem-cell transplantation in a patient with diffuse large B-cell lymphoma. 134
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations. 131
Predictive value of pretransplantation molecular minimal residual disease assessment by WT1 gene expression in FLT3-positive acute myeloid leukemia 131
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 129
Multipotent Progenitor Cells Are Present in Human Peripheral Blood. 129
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. 128
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 128
Clinical impact of CD200 expression in patients with acute myeloid leukemia and correlation with other molecular prognostic factors 127
Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib 126
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years 126
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response. 126
P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells 125
Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia 124
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. 123
Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. 122
Purging of chronic myelogenous leukemia cells by retrovirally expressed anti-bcr-abl ribozymes with specific cellular compartmentalization. 121
Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi 121
Management of immune thrombocytopenia in elderly patients 121
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma. 118
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results 118
“Overexpression of multidrug resistance-associated P-170 glycoprotein in acute non lymphocytic leukemia”. 117
Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia 117
Quality of life in elderly patients with essential thrombocythaemia. An Italian multicentre study. 116
Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases 116
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomas. 115
Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation 115
Autologous stem cell transplantation in chronic carriers of hepatitis B virus and hepatitis C virus affected by onco-hematologic diseases. 115
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)” 114
Autologus stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome. 113
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 113
Bendamustine in chronic lymphocytic leukemia: Outcome according to different clinical and biological prognostic factors in the everyday clinical practice. 113
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab. 113
Family history of cancer and risk of second malignancies in young cancer patients in Trieste, Italy. 112
Granulocyte-macrophage colony -stimulating factor in acute nonlymphocytic leukemia before and after chemo therapy”. 112
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 112
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin. 112
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 111
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission 111
Pre-Chemotherapy risk factors for invasive fungal diseases: Prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (seifem 2010-a multicenter study) 111
Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: A retrospective study from the Acute Leukemia Working Party of the EBMT 111
B-cell immune reconstitution after allogenic stem cell transplantation and its role in the development of chronic graft-versus-host disease 110
WHO classification and WPSS predict post-transplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 109
Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo). 109
Longitudinal follow-up of WT1 gene expression as monitoring of minimal residual disease in acute myeloid leukemia following allogeneic bone marrow transplant 108
Differences among young adults, adults and elderly chronic myeloid leukemia patients. 108
P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia. 107
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias 107
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell Transplantation 107
Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. 107
Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: A multicenter retrospective study based on donor availability 107
Multicentre survey to explore current survival of patients with acute myeloid leukaemia who failed induction chemotherapy 106
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. 105
Wilms' tumor 1 gene expression levels in acute promyelocytic leukemia compared to other acute myeloid leukemia subtypes 105
Nocardiosis with favourable clinical outcome in progressive B-chronic lymphocytic leukaemia 104
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia 104
“Case report: mdr-1 gene amplification in acute lymphoblastic leukemia prior to antileukemic treatment”. 104
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 103
CHOP-rituximab with pegylated liposomal doxorubicin for the treatment of elderly patients with diffuse large B-cell lymphoma 103
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia. 103
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study 103
Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey 103
Rituximab for the treatment of type II mixed cryoglobulinemia. 102
Paraneoplastic cerebellar degeneration associated with anti-neuronal anti-Tr antibodies in a patient with Hodgkin's disease 102
Response rate and survival after thalidomide-based therapy in 248 patients with myelodysplastic syndromes. 102
Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study. 102
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia 102
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome 102
Long-term efficacy and safety of nilotinib therapy after imatinib failure in eosinophilic myeloproliferative neoplasm and ETV6-ABL rearrangement 102
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy. 101
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations. 101
Unexpected phenotype of a typical NPM1 mutant 100
Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab. 100
High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+ patients 100
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT 100
Leukaemic infiltration of the retina at onset of Philadelphia-positive acute lymphoblastic leukaemia revealed by stratus optical coherence tomography 100
Multipotent Mesenchymal Stem Cells Can Be Isolated and Grown from Many Tissues (Bone Marrow, Liver and Heart) 100
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia 99
Efficacy and safety of peripheral blood stem cell mobilization and collection: a single-center experience in 190 allogeneic donors. 99
A comparison of allografting with autografting for newly diagnosed myeloma 99
Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera. 99
Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome. 99
A phase II study of α-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia 99
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia-- analysis of 848 patients 98
Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia. 98
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma. 98
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy 98
Surgical staging in Hodgkin's disease: the role of laparoscopic splenectomy 97
The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype 97
Long-term follow-up analysis after rituximab salvage therapy in adult patients with immune thrombocytopenia 97
FEASIBILITY OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH CD34 SELECTED STEM CELLS: OUTCOME AND IMMUNOLOGICAL COMPLICATIONS 96
Totale 11.472
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.147
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.286 0 0 0 0 0 0 0 0 0 428 1.085 773
2019/20208.347 467 426 319 1.245 632 1.322 940 978 622 640 182 574
2020/20214.787 134 577 144 555 207 594 354 579 601 182 568 292
2021/20222.955 115 341 150 218 85 143 179 140 50 481 604 449
2022/20232.663 394 150 29 308 249 784 14 189 367 36 82 61
2023/2024689 112 58 26 27 126 98 17 53 135 37 0 0
Totale 27.894